Life
FDA declines to approve ivonescimab for a group of lung cancer patients
A late-stage study found the drug delayed cancer progression, but fell short of showing that patients lived longer.
November 15, 2026 · 3 min read
The latest reporting, guides and features on medications.
A late-stage study found the drug delayed cancer progression, but fell short of showing that patients lived longer.
